Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2667359d5c0f750435cb5e252ee9a1b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31ad9268f9b3be03e280237eef4601e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b10cc7e582ed9ad7df71b9c26c271948 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdcdfca7fa364be9e9bbde0c4322dc99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c83132fe41342113c80bf85bdd11948e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1774 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate |
2009-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da609337c72651bed6a4dc5b3225f2fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e52d84d2dc5e4770e089fde19327af9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7faca30f47e7155f014a9f26ed7492c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71909e9c1002c9123cdb3b8f7a59dc0d |
publicationDate |
2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10350268-B2 |
titleOfInvention |
Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
abstract |
Medical use of alpha-1-microglobulin (A1M) in the treatment or prophylaxis of diseases wherein oxidative stress is a responsible factor in the progress of the disease. Notably, the present invention relates to the medical use of alpha-1-microglobulin in the treatment or prophylaxis of diseases or conditions associated with the presences of free radicals and/or free haemoglobin in the subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981963-B2 |
priorityDate |
2008-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |